kabutan

KAINOS Laboratories,Inc.(4556) Summary

4556
TSE Standard
KAINOS Laboratories,Inc.
2,267
JPY
(ー%)
Apr 28, 3:30 pm JST
14.23
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
15.9
PBR
1.34
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
2,267 JPY 14.22 USD
Previous Close Apr 27
2,267 JPY USD
High Apr 28, 9:00 am
2,267 JPY 14.24 USD
Low Apr 28, 9:00 am
2,267 JPY 14.21 USD
Volume
2,100
Trading Value
5.00M JPY 0.03M USD
VWAP
2267.0 JPY 14.24 USD
Minimum Trading Value
226,700 JPY 1,423 USD
Market Cap
0.01T JPY 0.06B USD
Number of Trades
8
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
Slightly Low
1-Year Average
16
1-Year High Feb 12, 2026
202
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 0 1,500
Apr 17, 2026 0 1,800
Apr 10, 2026 0 3,200
Apr 3, 2026 0 3,200
Mar 27, 2026 0 7,300
Company Profile
KAINOS Laboratories, Inc. is a mid-tier clinical diagnostics company specializing in renal function and allergy tests, with a focus on biochemistry and immunoserology.
Sector
Pharmaceuticals
KAINOS Laboratories, Inc. primarily engages in the manufacture and sale of in vitro diagnostic reagents and medical devices for clinical testing. The company operates independently without subsidiaries or affiliates, maintaining a continuous and close business relationship with Asahi Kasei Pharma. In the field of clinical diagnostics, KAINOS's main products include those for renal function and blood transfusion tests. The company particularly excels in biochemical and immunoserological testing, demonstrating its strengths in these areas. By providing essential products for diagnosis and treatment decisions in medical settings, KAINOS contributes to improving the quality of healthcare.